{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "10",
                "@year": "2023",
                "@timestamp": "2023-07-10T10:36:47.000047-04:00",
                "@month": "07"
            },
            "ait:date-sort": {
                "@day": "01",
                "@year": "2022",
                "@month": "11"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding": [
                {"xocs:funding-agency-matched-string": "Daiichi"},
                {
                    "xocs:funding-agency-matched-string": "Amgen",
                    "xocs:funding-agency": "Amgen",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100002429",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {
                    "xocs:funding-agency-matched-string": "Pfizer Inc.",
                    "xocs:funding-agency": "Pfizer",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100004319",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {
                    "xocs:funding-agency-matched-string": "AstraZeneca",
                    "xocs:funding-agency": "AstraZeneca",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100004325",
                    "xocs:funding-agency-country": "http://sws.geonames.org/2635167/"
                },
                {
                    "xocs:funding-agency-matched-string": "Novartis",
                    "xocs:funding-agency": "Novartis",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100004336",
                    "xocs:funding-agency-country": "http://sws.geonames.org/2658434/"
                },
                {
                    "xocs:funding-agency-matched-string": "Roche",
                    "xocs:funding-agency": "Roche",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100004337",
                    "xocs:funding-agency-country": "http://sws.geonames.org/2658434/"
                },
                {
                    "xocs:funding-agency-matched-string": "MSD",
                    "xocs:funding-agency-acronym": "MSD",
                    "xocs:funding-agency": "Meso Scale Diagnostics",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100007054",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {
                    "xocs:funding-agency-matched-string": "Boehringer Ingelheim",
                    "xocs:funding-agency": "Boehringer Ingelheim",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100008349",
                    "xocs:funding-agency-country": "http://sws.geonames.org/2921044/"
                },
                {
                    "xocs:funding-agency-matched-string": "Eisai",
                    "xocs:funding-agency": "Eisai",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/501100003769",
                    "xocs:funding-agency-country": "http://sws.geonames.org/1861060/"
                }
            ],
            "xocs:funding-addon-generated-timestamp": "2022-11-15T18:41:31.008Z",
            "xocs:funding-text": [
                {"$": "This study was sponsored by Pfizer Inc. Editorial support was provided by Jill Shults, PhD, of ICON plc (Blue Bell, PA, USA), and was funded by Pfizer Inc."},
                {"$": "This study was funded by Pfizer, which contributed to the study design; the collection, analysis and interpretation of data; the writing of the manuscript; and in the decision to submit the article for publication.The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Binghe Xu has been an advisor for Novartis and Roche, has received research funding from Hengrui, and has served on speakers bureaus for AstraZeneca, Pfizer Inc, Roche, and Eisai. Chiun-Sheng Huang has been an advisor for Amgen, AstraZeneca, Lilly, Novartis, Pfizer Inc, and Roche; has received research funding from Amgen, AstraZeneca, Daiichi Sankyo, EirGenix, Lilly, MSD, Novartis, OBI, Pfizer, and Roche; and has served on a speakers bureau for Roche. Virote Sriuranpong has received research funding from Roche, MSD, Novartis, Pfizer Inc, and AstraZeneca and has been an advisor for Roche, Novartis, Boehringer Ingelheim, MSD, Pfizer Inc, and Amgen. Roger Kai Cheong Ngan has received research funding from Pfizer Inc; has been an advisor for Pfizer Inc, Novartis, Sanofi, AstraZeneca, Lilly, MSD, Zai Lab, Roche, and Eisai; and has served on speakers bureaus for Novartis, AstraZeneca, Sanofi, Pfizer Inc, Zai Lab, Eisai, Lilly, and MSD. Xinwei Wang is an employee of and has stocks or stock options in Pfizer Inc. Huadong Zhao is an employee of Pfizer Inc. Xichun Hu, Wei Li, Tao Sun, Kunwei Shen, Shusen Wang, Ying Cheng, Qingyuan Zhang, Shude Cui, Zhongsheng Tong, Cuizhi Geng, Erwei Song, and Yee Hong Chia have no conflicts of interest to disclose."}
            ],
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"
        }},
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "China",
                            "@afid": "60073456",
                            "@country": "chn",
                            "city": "Beijing",
                            "organization": [
                                {"$": "National Cancer Center/Cancer Hospital"},
                                {"$": "Chinese Academy of Medical Sciences and Peking Union Medical College"}
                            ],
                            "affiliation-id": [
                                {"@afid": "60073456"},
                                {"@afid": "60122781"}
                            ],
                            "@affiliation-instance-id": "S0959804922004890-c19775696db6dba53c02a7c0d3e4bf26",
                            "ce:source-text": "National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"
                        },
                        "author": [{
                            "ce:given-name": "Binghe",
                            "preferred-name": {
                                "ce:given-name": "Binghe",
                                "ce:initials": "B.",
                                "ce:surname": "Xu",
                                "ce:indexed-name": "Xu B."
                            },
                            "@seq": "1",
                            "@author-instance-id": "S0959804922004890-b136b529489a8954e55090d0c546f5fb",
                            "ce:initials": "B.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Xu",
                            "@auid": "7404589280",
                            "ce:indexed-name": "Xu B."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "China",
                            "@afid": "60108904",
                            "@country": "chn",
                            "city": "Shanghai",
                            "organization": {"$": "Fudan University Shanghai Cancer Center"},
                            "affiliation-id": {"@afid": "60108904"},
                            "@affiliation-instance-id": "S0959804922004890-bd7e8a12ac98d1bf04d50063c7660f47",
                            "ce:source-text": "Fudan University Shanghai Cancer Center, Shanghai, China"
                        },
                        "author": [{
                            "ce:given-name": "Xichun",
                            "preferred-name": {
                                "ce:given-name": "Xichun",
                                "ce:initials": "X.",
                                "ce:surname": "Hu",
                                "ce:indexed-name": "Hu X."
                            },
                            "@seq": "2",
                            "@author-instance-id": "S0959804922004890-eef51d08609076cc791c0bd9249426ba",
                            "ce:initials": "X.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Hu",
                            "@auid": "57216569158",
                            "ce:indexed-name": "Hu X."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "China",
                            "@afid": "60122381",
                            "@country": "chn",
                            "city": "Changchun",
                            "organization": {"$": "The First Hospital of Jilin University"},
                            "affiliation-id": {"@afid": "60122381"},
                            "@affiliation-instance-id": "S0959804922004890-0749223c4b051c08393b0abe5fda6603",
                            "ce:source-text": "The First Hospital of Jilin University, Changchun, China"
                        },
                        "author": [{
                            "ce:given-name": "Wei",
                            "preferred-name": {
                                "ce:given-name": "Wei",
                                "ce:initials": "W.",
                                "ce:surname": "Li",
                                "ce:indexed-name": "Li W."
                            },
                            "@seq": "3",
                            "@author-instance-id": "S0959804922004890-90c55994e6db4ad3527637c72d8b51eb",
                            "ce:initials": "W.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Li",
                            "@auid": "57196305473",
                            "ce:indexed-name": "Li W."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "China",
                            "address-part": "Liaoning",
                            "@afid": "60008872",
                            "@country": "chn",
                            "city": "Shenyang",
                            "organization": {"$": "Cancer Hospital of China Medical University/Liaoning Cancer Hospital"},
                            "affiliation-id": [
                                {"@afid": "60008872"},
                                {"@afid": "60073659"}
                            ],
                            "@affiliation-instance-id": "S0959804922004890-b0a28626a2315ba11ae63eb32c622dbd",
                            "ce:source-text": "Cancer Hospital of China Medical University/Liaoning Cancer Hospital, Shenyang, Liaoning, China"
                        },
                        "author": [{
                            "ce:given-name": "Tao",
                            "preferred-name": {
                                "ce:given-name": "Tao",
                                "ce:initials": "T.",
                                "ce:surname": "Sun",
                                "ce:indexed-name": "Sun T."
                            },
                            "@seq": "4",
                            "@author-instance-id": "S0959804922004890-212ab5ec49342f973961f105dc7d8561",
                            "ce:initials": "T.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Sun",
                            "@auid": "35235673700",
                            "ce:indexed-name": "Sun T."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "China",
                            "@afid": "60024452",
                            "@country": "chn",
                            "city": "Shanghai",
                            "organization": {"$": "Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine"},
                            "affiliation-id": {"@afid": "60024452"},
                            "@affiliation-instance-id": "S0959804922004890-1495557459b13e16dc75d20fc5d348e1",
                            "ce:source-text": "Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China"
                        },
                        "author": [{
                            "ce:given-name": "Kunwei",
                            "preferred-name": {
                                "ce:given-name": "Kunwei",
                                "ce:initials": "K.",
                                "ce:surname": "Shen",
                                "ce:indexed-name": "Shen K."
                            },
                            "@seq": "5",
                            "@author-instance-id": "S0959804922004890-31eb2f4e5fe36f8cecb2582d11ad4aa1",
                            "ce:initials": "K.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Shen",
                            "@auid": "7201458295",
                            "ce:indexed-name": "Shen K."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "China",
                            "@afid": "60082502",
                            "@country": "chn",
                            "city": "Guangzhou",
                            "organization": {"$": "Sun Yat-Sen University Cancer Center"},
                            "affiliation-id": {"@afid": "60082502"},
                            "@affiliation-instance-id": "S0959804922004890-b986d55386ae1a250c6fead786eda5e8",
                            "ce:source-text": "Fudan University Shanghai Cancer Center, Shanghai, China;"
                        },
                        "author": [{
                            "ce:given-name": "Shusen",
                            "preferred-name": {
                                "ce:given-name": "Shusen",
                                "ce:initials": "S.",
                                "ce:surname": "Wang",
                                "ce:indexed-name": "Wang S."
                            },
                            "@seq": "6",
                            "@author-instance-id": "S0959804922004890-7e6cf4f87591fb624a4d954fb48dbf51",
                            "ce:initials": "S.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Wang",
                            "@auid": "36807318600",
                            "ce:indexed-name": "Wang S."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "China",
                            "@afid": "60082194",
                            "@country": "chn",
                            "city": "Changchun",
                            "organization": {"$": "Jilin Provincial Cancer Hospital"},
                            "affiliation-id": {"@afid": "60082194"},
                            "@affiliation-instance-id": "S0959804922004890-7e51319ec8a536c9d3f69d8d413c079f",
                            "ce:source-text": "Jilin Provincial Cancer Hospital, Changchun, China"
                        },
                        "author": [{
                            "ce:given-name": "Ying",
                            "preferred-name": {
                                "ce:given-name": "Ying",
                                "ce:initials": "Y.",
                                "ce:surname": "Cheng",
                                "ce:indexed-name": "Cheng Y."
                            },
                            "@seq": "7",
                            "@author-instance-id": "S0959804922004890-45d47e30827ab0e181c3c09a140d3484",
                            "ce:initials": "Y.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Cheng",
                            "@auid": "9437171300",
                            "ce:indexed-name": "Cheng Y."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "China",
                            "@afid": "60021615",
                            "@country": "chn",
                            "city": "Harbin",
                            "organization": {"$": "Harbin Medical University Cancer Hospital/Oncology Department"},
                            "affiliation-id": {"@afid": "60021615"},
                            "@affiliation-instance-id": "S0959804922004890-e911d5f2ef10ec18d58ce0d770444049",
                            "ce:source-text": "Harbin Medical University Cancer Hospital/Oncology Department, Harbin, China"
                        },
                        "author": [{
                            "ce:given-name": "Qingyuan",
                            "preferred-name": {
                                "ce:given-name": "Qingyuan",
                                "ce:initials": "Q.",
                                "ce:surname": "Zhang",
                                "ce:indexed-name": "Zhang Q."
                            },
                            "@seq": "8",
                            "@author-instance-id": "S0959804922004890-991866dfaae9874838ae760ad4916238",
                            "ce:initials": "Q.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Zhang",
                            "@auid": "36492586800",
                            "ce:indexed-name": "Zhang Q."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "China",
                            "@afid": "128127093",
                            "@country": "chn",
                            "city": "Zhengzhou",
                            "organization": {"$": "Henan Cancer Hospital"},
                            "affiliation-id": {"@afid": "128127093"},
                            "@affiliation-instance-id": "S0959804922004890-8ba1f767b3d12570ec71b7df5d4e14c7",
                            "ce:source-text": "Henan Cancer Hospital, Zhengzhou, China"
                        },
                        "author": [{
                            "ce:given-name": "Shude",
                            "preferred-name": {
                                "ce:given-name": "Shude",
                                "ce:initials": "S.",
                                "ce:surname": "Cui",
                                "ce:indexed-name": "Cui S."
                            },
                            "@seq": "9",
                            "@author-instance-id": "S0959804922004890-5cac14709d69f9025f0f4f8fc9f121ee",
                            "ce:initials": "S.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Cui",
                            "@auid": "7202413749",
                            "ce:indexed-name": "Cui S."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "China",
                            "@afid": "60017260",
                            "@country": "chn",
                            "city": "Tianjin",
                            "organization": {"$": "Tianjin Cancer Hospital/Breast Cancer Department"},
                            "affiliation-id": {"@afid": "60017260"},
                            "@affiliation-instance-id": "S0959804922004890-da70c531eb239b219a2c93827140e965",
                            "ce:source-text": "Tianjin Cancer Hospital/Breast Cancer Department, Tianjin, China"
                        },
                        "author": [{
                            "ce:given-name": "Zhongsheng",
                            "preferred-name": {
                                "ce:given-name": "Zhongsheng",
                                "ce:initials": "Z.",
                                "ce:surname": "Tong",
                                "ce:indexed-name": "Tong Z."
                            },
                            "@seq": "10",
                            "@author-instance-id": "S0959804922004890-087fbac704f55e037e6f06c568c583ba",
                            "ce:initials": "Z.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Tong",
                            "@auid": "14014497700",
                            "ce:indexed-name": "Tong Z."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "China",
                            "@afid": "60009884",
                            "@country": "chn",
                            "city": "Shijiazhuang",
                            "organization": {"$": "Fourth Hospital of Hebei Medical University"},
                            "affiliation-id": {"@afid": "60009884"},
                            "@affiliation-instance-id": "S0959804922004890-f9e4d5e2ba0d18f2f5db5bf167573239",
                            "ce:source-text": "Fourth Hospital of Hebei Medical University, Shijiazhuang, China"
                        },
                        "author": [{
                            "ce:given-name": "Cuizhi",
                            "preferred-name": {
                                "ce:given-name": "Cuizhi",
                                "ce:initials": "C.",
                                "ce:surname": "Geng",
                                "ce:indexed-name": "Geng C."
                            },
                            "@seq": "11",
                            "@author-instance-id": "S0959804922004890-bf13a61fd827395fdd8032b5df3c0a20",
                            "ce:initials": "C.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Geng",
                            "@auid": "26425095100",
                            "ce:indexed-name": "Geng C."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "China",
                            "@afid": "60021182",
                            "@country": "chn",
                            "city": "Guangzhou",
                            "organization": [
                                {"$": "Sun Yat-sen Memorial Hospital"},
                                {"$": "Sun Yat-Sen University"}
                            ],
                            "affiliation-id": [
                                {"@afid": "60021182"},
                                {"@afid": "60122357"}
                            ],
                            "@affiliation-instance-id": "S0959804922004890-ebb4b0a2734d7cc1f7992105993b87df",
                            "ce:source-text": "Sun Yat-sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China"
                        },
                        "author": [{
                            "ce:given-name": "Erwei",
                            "preferred-name": {
                                "ce:given-name": "Erwei",
                                "ce:initials": "E.",
                                "ce:surname": "Song",
                                "ce:indexed-name": "Song E."
                            },
                            "@seq": "12",
                            "@author-instance-id": "S0959804922004890-88fdfe5584e53e3244877cd3e80562f2",
                            "ce:initials": "E.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Song",
                            "@auid": "7101904256",
                            "ce:indexed-name": "Song E."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Taiwan",
                            "@afid": "60025370",
                            "@country": "twn",
                            "city": "Taipei",
                            "organization": {"$": "National Taiwan University Hospital and National Taiwan University College of Medicine"},
                            "affiliation-id": [
                                {"@afid": "60025370"},
                                {"@afid": "60073385"}
                            ],
                            "@affiliation-instance-id": "S0959804922004890-74bb8d019025b6f1213162f7c5423f00",
                            "ce:source-text": "National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan"
                        },
                        "author": [{
                            "ce:given-name": "Chiun-Sheng",
                            "preferred-name": {
                                "ce:given-name": "Chiun Sheng",
                                "ce:initials": "C.S.",
                                "ce:surname": "Huang",
                                "ce:indexed-name": "Huang C.S."
                            },
                            "@seq": "13",
                            "@author-instance-id": "S0959804922004890-56fe5981f14396e7fa40104ae8d2b82d",
                            "ce:initials": "C.-S.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Huang",
                            "@auid": "57217997695",
                            "ce:indexed-name": "Huang C.-S."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60022183",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University and The King Chulalongkorn Memorial Hospital"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60022183",
                                    "@dptid": "104136204"
                                },
                                {"@afid": "60028190"}
                            ],
                            "@affiliation-instance-id": "S0959804922004890-2676213816437d3c5d87539dbd96934d",
                            "ce:source-text": "Faculty of Medicine, Chulalongkorn University and the King Chulalongkorn Memorial Hospital, Bangkok, Thailand",
                            "@dptid": "104136204"
                        },
                        "author": [{
                            "ce:given-name": "Virote",
                            "preferred-name": {
                                "ce:given-name": "Virote",
                                "ce:initials": "V.",
                                "ce:surname": "Sriuranpong",
                                "ce:indexed-name": "Sriuranpong V."
                            },
                            "@seq": "14",
                            "@author-instance-id": "S0959804922004890-22e218eaadcaddaa8706ccf781a93102",
                            "ce:initials": "V.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Sriuranpong",
                            "@auid": "6603599644",
                            "ce:indexed-name": "Sriuranpong V."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Hong Kong",
                            "@afid": "60006541",
                            "@country": "hkg",
                            "organization": [
                                {"$": "Department of Clinical Oncology"},
                                {"$": "The University of Hong Kong"}
                            ],
                            "affiliation-id": {
                                "@afid": "60006541",
                                "@dptid": "113916987"
                            },
                            "@affiliation-instance-id": "S0959804922004890-c7d9032dd18116ee9b9fcb1046b3635a",
                            "ce:source-text": "Department of Clinical Oncology, The University of Hong Kong, Hong Kong",
                            "@dptid": "113916987"
                        },
                        "author": [{
                            "ce:given-name": "Roger K.C.",
                            "preferred-name": {
                                "ce:given-name": "Roger K.C.",
                                "ce:initials": "R.K.C.",
                                "ce:surname": "Ngan",
                                "ce:indexed-name": "Ngan R.K.C."
                            },
                            "@seq": "15",
                            "@author-instance-id": "S0959804922004890-d62e9f95d9c2ee271821c25bbe5fb99f",
                            "ce:initials": "R.K.C.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Ngan",
                            "@auid": "57222641833",
                            "ce:indexed-name": "Ngan R.K.C."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Singapore",
                            "@afid": "60002481",
                            "@country": "sgp",
                            "organization": {"$": "Tan Tock Seng Hospital"},
                            "affiliation-id": {"@afid": "60002481"},
                            "@affiliation-instance-id": "S0959804922004890-1946293972b243d78d84dd73e272efb7",
                            "ce:source-text": "The First Hospital of Jilin University, Changchun, China;"
                        },
                        "author": [{
                            "ce:given-name": "Yee H.",
                            "preferred-name": {
                                "ce:given-name": "Yee H.",
                                "ce:initials": "Y.H.",
                                "ce:surname": "Chia",
                                "ce:indexed-name": "Chia Y.H."
                            },
                            "@seq": "16",
                            "@author-instance-id": "S0959804922004890-c2a600b4d471f231960ce4df496106e8",
                            "ce:initials": "Y.H.",
                            "@date-locked": "2023-05-05T07:48:46.376",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Chia",
                            "@auid": "35290374300",
                            "ce:indexed-name": "Chia Y.H."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "China",
                            "@afid": "60006989",
                            "@country": "chn",
                            "city": "Shanghai",
                            "organization": [
                                {"$": "Pfizer (China) R&D Co."},
                                {"$": "Ltd."}
                            ],
                            "affiliation-id": {"@afid": "60006989"},
                            "@affiliation-instance-id": "S0959804922004890-fcb2b417163359e36f0b0387ab559341",
                            "ce:source-text": "Pfizer (China) R&D Co., Ltd., Shanghai, China"
                        },
                        "author": [
                            {
                                "ce:given-name": "Xinwei",
                                "preferred-name": {
                                    "ce:given-name": "Xinwei",
                                    "ce:initials": "X.",
                                    "ce:surname": "Wang",
                                    "ce:indexed-name": "Wang X."
                                },
                                "@seq": "17",
                                "@author-instance-id": "S0959804922004890-b384a290af0348ebe8a8f7e2fe8b2daa",
                                "ce:initials": "X.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Wang",
                                "@auid": "57900513500",
                                "ce:indexed-name": "Wang X."
                            },
                            {
                                "ce:given-name": "Huadong",
                                "preferred-name": {
                                    "ce:given-name": "Huadong",
                                    "ce:initials": "H.",
                                    "ce:surname": "Zhao",
                                    "ce:indexed-name": "Zhao H."
                                },
                                "@seq": "18",
                                "@author-instance-id": "S0959804922004890-90a650b01d14c243b741b7d003b18d5d",
                                "ce:initials": "H.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Zhao",
                                "@auid": "57222871740",
                                "ce:indexed-name": "Zhao H."
                            }
                        ]
                    }
                ],
                "citation-title": "Palbociclib plus letrozole versus placebo plus letrozole in Asian postmenopausal women with oestrogen receptor\u2013positive/human epidermal growth factor receptor 2\u2013negative advanced breast cancer: Primary results from PALOMA-4",
                "abstracts": "© 2022 Elsevier LtdBackground: The cyclin-dependent kinase 4/6 inhibitor palbociclib has demonstrated efficacy and a manageable safety profile in combination with endocrine therapy in women with oestrogen receptor\u2013positive (ER+)/human epidermal growth factor receptor 2\u2013negative (HER2\u2013) advanced breast cancer (ABC) in international phase 3 trials. The phase 3 PALOMA-4 trial evaluated the efficacy and safety of palbociclib plus letrozole versus placebo plus letrozole in Asian women with ER+/HER2\u2013 ABC. Methods: Postmenopausal women (n = 340) with no prior systemic treatment for advanced disease were randomised 1:1 to palbociclib (125 mg/d orally; 3 weeks on, 1 week off) plus letrozole (2.5 mg/d orally; continuously) or placebo plus letrozole. The primary end-point was investigator-assessed progression-free survival (PFS). Secondary end-points included tumour response and safety. Results: Median (95% CI) PFS was 21.5 (16.6\u201324.9) months with palbociclib plus letrozole and 13.9 (13.7\u201316.6) months with placebo plus letrozole (hazard ratio, 0.68 [95% CI, 0.53\u20130.87]; P = 0.0012). Consistent with the established safety profile, the most common adverse events (AEs) with palbociclib plus letrozole were neutropenia, leukopenia, thrombocytopaenia, and anaemia. Grade 3/4 neutropenia was reported in 84.5% of patients in the palbociclib arm versus 1.2% in the placebo arm. One serious AE of febrile neutropenia in the palbociclib group was reported. Conclusions: Findings from PALOMA-4 support the efficacy and safety of first-line palbociclib plus letrozole in postmenopausal Asian women with ER+/HER2\u2013 ABC. No new safety concerns of palbociclib plus letrozole were identified. Trial registration: Clinicaltrials. gov, NCT02297438.",
                "correspondence": {
                    "affiliation": {
                        "country": "China",
                        "address-part": "No.17 Pan Jia Yuan Nan Li, Chaoyang District",
                        "postal-code": "100021",
                        "@country": "chn",
                        "city": "Beijing",
                        "organization": [
                            {"$": "National Cancer Center/Cancer Hospital"},
                            {"$": "Chinese Academy of Medical Sciences and Peking Union Medical College"}
                        ]
                    },
                    "person": {
                        "ce:given-name": "Binghe",
                        "ce:initials": "B.",
                        "ce:surname": "Xu",
                        "ce:indexed-name": "Xu B."
                    }
                },
                "citation-info": {
                    "author-keywords": {"author-keyword": [
                        {
                            "$": "Advanced breast cancer",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Asian",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Letrozole",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Oestrogen receptor\u2013positive",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Palbociclib",
                            "@xml:lang": "eng",
                            "@original": "y"
                        }
                    ]},
                    "citation-type": {"@code": "ar"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "website": {"ce:e-address": {
                        "$": "http://www.journals.elsevier.com/european-journal-of-cancer/",
                        "@type": "email"
                    }},
                    "translated-sourcetitle": {
                        "$": "European Journal of Cancer",
                        "@xml:lang": "eng"
                    },
                    "volisspag": {
                        "voliss": {"@volume": "175"},
                        "pagerange": {
                            "@first": "236",
                            "@last": "245"
                        }
                    },
                    "@type": "j",
                    "sourcetitle": "European Journal of Cancer",
                    "publicationdate": {
                        "month": "11",
                        "year": "2022",
                        "date-text": "November 2022",
                        "day": "01"
                    },
                    "codencode": "EJCAE",
                    "sourcetitle-abbrev": "Eur. J. Cancer",
                    "@country": "gbr",
                    "issn": [
                        {
                            "$": "18790852",
                            "@type": "electronic"
                        },
                        {
                            "$": "09598049",
                            "@type": "print"
                        }
                    ],
                    "publicationyear": {"@first": "2022"},
                    "publisher": {"publishername": "Elsevier Ltd"},
                    "@srcid": "29761"
                },
                "enhancement": {
                    "classificationgroup": {"classifications": [
                        {
                            "@type": "EMCLASS",
                            "classification": [
                                {
                                    "classification-code": "10",
                                    "classification-description": "Obstetrics and Gynecology"
                                },
                                {
                                    "classification-code": "16",
                                    "classification-description": "Cancer"
                                },
                                {
                                    "classification-code": "37",
                                    "classification-description": "Drug Literature Index"
                                },
                                {
                                    "classification-code": "38",
                                    "classification-description": "Adverse Reactions Titles"
                                }
                            ]
                        },
                        {
                            "@type": "ASJC",
                            "classification": [
                                {"$": "2730"},
                                {"$": "1306"}
                            ]
                        },
                        {
                            "@type": "SUBJABBR",
                            "classification": [
                                {"$": "MEDI"},
                                {"$": "BIOC"}
                            ]
                        }
                    ]},
                    "chemicalgroup": {"chemicals": [
                        {
                            "@source": "esbd",
                            "chemical": [
                                {
                                    "cas-registry-number": [
                                        {"$": "9000-86-6"},
                                        {"$": "9014-30-6"}
                                    ],
                                    "enzyme-commission-number": "EC 2.6.1.2",
                                    "chemical-name": "alanine aminotransferase"
                                },
                                {
                                    "cas-registry-number": "9000-97-9",
                                    "enzyme-commission-number": "EC 2.6.1.1",
                                    "chemical-name": "aspartate aminotransferase"
                                },
                                {
                                    "cas-registry-number": "147014-97-9",
                                    "chemical-name": "cyclin dependent kinase 4"
                                },
                                {
                                    "cas-registry-number": "137632-09-8",
                                    "chemical-name": "epidermal growth factor receptor 2"
                                },
                                {
                                    "cas-registry-number": "85876-02-4",
                                    "enzyme-commission-number": "EC 2.3.2.2",
                                    "chemical-name": "gamma glutamyltransferase"
                                },
                                {
                                    "cas-registry-number": [
                                        {"$": "65807-02-5"},
                                        {"$": "145781-92-6"}
                                    ],
                                    "chemical-name": "goserelin"
                                },
                                {
                                    "cas-registry-number": "9008-02-0",
                                    "chemical-name": "hemoglobin"
                                },
                                {
                                    "cas-registry-number": "112809-51-5",
                                    "chemical-name": "letrozole"
                                },
                                {
                                    "cas-registry-number": [
                                        {"$": "53714-56-0"},
                                        {"$": "74381-53-6"},
                                        {"$": "944347-41-5"}
                                    ],
                                    "chemical-name": "leuprorelin"
                                },
                                {
                                    "cas-registry-number": [
                                        {"$": "571190-30-2"},
                                        {"$": "827022-33-3"}
                                    ],
                                    "chemical-name": "palbociclib"
                                },
                                {
                                    "cas-registry-number": "10540-29-1",
                                    "chemical-name": "tamoxifen"
                                },
                                {
                                    "cas-registry-number": "89778-26-7",
                                    "chemical-name": "toremifene"
                                }
                            ]
                        },
                        {
                            "@source": "nlm",
                            "chemical": [
                                {"chemical-name": "Cyclin-Dependent Kinase 4"},
                                {"chemical-name": "ERBB2 protein, human"},
                                {"chemical-name": "Letrozole"},
                                {"chemical-name": "palbociclib"},
                                {"chemical-name": "Piperazines"},
                                {"chemical-name": "Pyridines"},
                                {"chemical-name": "Receptor, ErbB-2"},
                                {"chemical-name": "Receptors, Estrogen"}
                            ]
                        }
                    ]}
                },
                "grantlist": {
                    "@complete": "y",
                    "grant-text": {
                        "$": "This study was funded by Pfizer, which contributed to the study design; the collection, analysis and interpretation of data; the writing of the manuscript; and in the decision to submit the article for publication.The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Binghe Xu has been an advisor for Novartis and Roche, has received research funding from Hengrui, and has served on speakers bureaus for AstraZeneca, Pfizer Inc, Roche, and Eisai. Chiun-Sheng Huang has been an advisor for Amgen, AstraZeneca, Lilly, Novartis, Pfizer Inc, and Roche; has received research funding from Amgen, AstraZeneca, Daiichi Sankyo, EirGenix, Lilly, MSD, Novartis, OBI, Pfizer, and Roche; and has served on a speakers bureau for Roche. Virote Sriuranpong has received research funding from Roche, MSD, Novartis, Pfizer Inc, and AstraZeneca and has been an advisor for Roche, Novartis, Boehringer Ingelheim, MSD, Pfizer Inc, and Amgen. Roger Kai Cheong Ngan has received research funding from Pfizer Inc; has been an advisor for Pfizer Inc, Novartis, Sanofi, AstraZeneca, Lilly, MSD, Zai Lab, Roche, and Eisai; and has served on speakers bureaus for Novartis, AstraZeneca, Sanofi, Pfizer Inc, Zai Lab, Eisai, Lilly, and MSD. Xinwei Wang is an employee of and has stocks or stock options in Pfizer Inc. Huadong Zhao is an employee of Pfizer Inc. Xichun Hu, Wei Li, Tao Sun, Kunwei Shen, Shusen Wang, Ying Cheng, Qingyuan Zhang, Shude Cui, Zhongsheng Tong, Cuizhi Geng, Erwei Song, and Yee Hong Chia have no conflicts of interest to disclose.",
                        "@xml:lang": "eng"
                    },
                    "grant": [
                        {
                            "grant-acronym": "OBI",
                            "grant-agency": {
                                "@iso-code": "can",
                                "$": "Ontario Brain Institute"
                            },
                            "grant-agency-id": "100008914"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Amgen"
                            },
                            "grant-agency-id": "100002429"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Amgen"
                            },
                            "grant-agency-id": "100002429"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Amgen"
                            },
                            "grant-agency-id": "100002429"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "gbr",
                                "$": "AstraZeneca"
                            },
                            "grant-agency-id": "100004325"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "gbr",
                                "$": "AstraZeneca"
                            },
                            "grant-agency-id": "100004325"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "gbr",
                                "$": "AstraZeneca"
                            },
                            "grant-agency-id": "100004325"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "gbr",
                                "$": "AstraZeneca"
                            },
                            "grant-agency-id": "100004325"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "gbr",
                                "$": "AstraZeneca"
                            },
                            "grant-agency-id": "100004325"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "gbr",
                                "$": "AstraZeneca"
                            },
                            "grant-agency-id": "100004325"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "jpn",
                                "$": "Eisai"
                            },
                            "grant-agency-id": "501100003769"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "che",
                                "$": "Novartis"
                            },
                            "grant-agency-id": "100004336"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "che",
                                "$": "Novartis"
                            },
                            "grant-agency-id": "100004336"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "che",
                                "$": "Novartis"
                            },
                            "grant-agency-id": "100004336"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "che",
                                "$": "Novartis"
                            },
                            "grant-agency-id": "100004336"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "che",
                                "$": "Novartis"
                            },
                            "grant-agency-id": "100004336"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "che",
                                "$": "Novartis"
                            },
                            "grant-agency-id": "100004336"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "che",
                                "$": "Novartis"
                            },
                            "grant-agency-id": "100004336"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Pfizer"
                            },
                            "grant-agency-id": "100004319"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Pfizer"
                            },
                            "grant-agency-id": "100004319"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Pfizer"
                            },
                            "grant-agency-id": "100004319"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Pfizer"
                            },
                            "grant-agency-id": "100004319"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Pfizer"
                            },
                            "grant-agency-id": "100004319"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Pfizer"
                            },
                            "grant-agency-id": "100004319"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Pfizer"
                            },
                            "grant-agency-id": "100004319"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Pfizer"
                            },
                            "grant-agency-id": "100004319"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Pfizer"
                            },
                            "grant-agency-id": "100004319"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Pfizer"
                            },
                            "grant-agency-id": "100004319"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Pfizer"
                            },
                            "grant-agency-id": "100004319"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "che",
                                "$": "Roche"
                            },
                            "grant-agency-id": "100004337"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "che",
                                "$": "Roche"
                            },
                            "grant-agency-id": "100004337"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "che",
                                "$": "Roche"
                            },
                            "grant-agency-id": "100004337"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "che",
                                "$": "Roche"
                            },
                            "grant-agency-id": "100004337"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "che",
                                "$": "Roche"
                            },
                            "grant-agency-id": "100004337"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "che",
                                "$": "Roche"
                            },
                            "grant-agency-id": "100004337"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Sanofi"
                            },
                            "grant-agency-id": "100004339"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Sanofi"
                            },
                            "grant-agency-id": "100004339"
                        }
                    ]
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2022 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "dbcollection": [
                    {"$": "EMBASE"},
                    {"$": "REAXYS"},
                    {"$": "REAXYSCAR"},
                    {"$": "RMC"},
                    {"$": "SCOPUS"},
                    {"$": "Scopusbase"},
                    {"$": "MEDL"}
                ],
                "history": {"date-created": {
                    "@day": "29",
                    "@year": "2022",
                    "@timestamp": "BST 07:31:48",
                    "@month": "09"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "2020323516",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "943058753",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "20220859728",
                            "@idtype": "EMBASE"
                        },
                        {
                            "$": "2022232422",
                            "@idtype": "REAXYS"
                        },
                        {
                            "$": "20222817853",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "2022433389",
                            "@idtype": "RMC"
                        },
                        {
                            "$": "20223327362",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "85138510141",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85138510141",
                            "@idtype": "SGR"
                        },
                        {
                            "$": "639111080",
                            "@idtype": "PUIsecondary"
                        },
                        {
                            "$": "36155117",
                            "@idtype": "MEDL"
                        },
                        {
                            "$": "77060399",
                            "@idtype": "OSIN"
                        }
                    ],
                    "ce:pii": "S0959804922004890",
                    "ce:ern": "pii:S0959804922004890",
                    "ce:doi": "10.1016/j.ejca.2022.08.012"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "24",
                "reference": [
                    {
                        "ref-fulltext": "Lin, C.H., Yap, Y.S., Lee, K.H., et al. Contrasting epidemiology and clinicopathology of female breast cancer in Asians vs the US population. J Natl Cancer Inst 111:12 (2019), 1298\u20131306.",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Contrasting epidemiology and clinicopathology of female breast cancer in Asians vs the US population"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib1",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85068867455",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "111",
                                    "@issue": "12"
                                },
                                "pagerange": {
                                    "@first": "1298",
                                    "@last": "1306"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.H.",
                                        "@_fa": "true",
                                        "ce:surname": "Lin",
                                        "ce:indexed-name": "Lin C.H."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "Y.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Yap",
                                        "ce:indexed-name": "Yap Y.S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K.H.",
                                        "@_fa": "true",
                                        "ce:surname": "Lee",
                                        "ce:indexed-name": "Lee K.H."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Natl Cancer Inst"
                        },
                        "ce:source-text": "Lin CH, Yap YS, Lee KH, et al. Contrasting epidemiology and clinicopathology of female breast cancer in Asians vs the US population. J Natl Cancer Inst. 2019;111(12):1298-1306."
                    },
                    {
                        "ref-fulltext": "Sung, H., Ferlay, J., Siegel, R.L., et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:3 (2021), 209\u2013249.",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib2",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85100345654",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "71",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "209",
                                    "@last": "249"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Sung",
                                        "ce:indexed-name": "Sung H."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Ferlay",
                                        "ce:indexed-name": "Ferlay J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Siegel",
                                        "ce:indexed-name": "Siegel R.L."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "CA Cancer J Clin"
                        },
                        "ce:source-text": "Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-249."
                    },
                    {
                        "ref-fulltext": "National Comprehensive Cancer Network. NCCN clinical Practice guidelines in Oncology (NCCN Guidelines®) breast cancer version 4.2021. April 28, 2021, National Comprehensive Cancer Network.",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "NCCN clinical Practice guidelines in Oncology (NCCN Guidelines®) breast cancer version 4.2021"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib3",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85138557143",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "National Comprehensive Cancer Network",
                            "ref-authors": {"collaboration": {
                                "@seq": "1",
                                "ce:text": "National Comprehensive Cancer Network",
                                "ce:indexed-name": "National Comprehensive Cancer Network"
                            }}
                        },
                        "ce:source-text": "National Comprehensive Cancer Network. NCCN clinical Practice guidelines in Oncology (NCCN Guidelines®) breast cancer version 4.2021. National Comprehensive Cancer Network; April 28, 2021."
                    },
                    {
                        "ref-fulltext": "IBRANCE® capsules (palbociclib), 2019, Full Prescribing Information, Pfizer Inc, New York, NY.",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib4",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85096343714",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "Full Prescribing Information, Pfizer Inc New York, NY",
                            "ref-sourcetitle": "IBRANCE® capsules (palbociclib)"
                        },
                        "ce:source-text": "IBRANCE® capsules (palbociclib). Full Prescribing Information, Pfizer Inc, New York, NY, 2019."
                    },
                    {
                        "ref-fulltext": "Finn, R.S., Crown, J.P., Lang, I., et al. The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study. Lancet Oncol 16:1 (2015), 25\u201335.",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib5",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84922369296",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "16",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "25",
                                    "@last": "35"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "R.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Finn",
                                        "ce:indexed-name": "Finn R.S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.P.",
                                        "@_fa": "true",
                                        "ce:surname": "Crown",
                                        "ce:indexed-name": "Crown J.P."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "I.",
                                        "@_fa": "true",
                                        "ce:surname": "Lang",
                                        "ce:indexed-name": "Lang I."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Oncol"
                        },
                        "ce:source-text": "Finn RS, Crown JP, Lang I, et al. The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study. Lancet Oncol. 2015;16(1):25-35."
                    },
                    {
                        "ref-fulltext": "Finn, R.S., Martin, M., Rugo, H.S., et al. Palbociclib and letrozole in advanced breast cancer. N Engl J Med 375:20 (2016), 1925\u20131936.",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Palbociclib and letrozole in advanced breast cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib6",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84995633338",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "375",
                                    "@issue": "20"
                                },
                                "pagerange": {
                                    "@first": "1925",
                                    "@last": "1936"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "R.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Finn",
                                        "ce:indexed-name": "Finn R.S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Martin",
                                        "ce:indexed-name": "Martin M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "H.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Rugo",
                                        "ce:indexed-name": "Rugo H.S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Finn RS, Martin M, Rugo HS, et al. Palbociclib and letrozole in advanced breast cancer. N Engl J Med. 2016;375(20):1925-1936."
                    },
                    {
                        "ref-fulltext": "Turner, N.C., Ro, J., Andre, F., et al. Palbociclib in hormone-receptor-positive advanced breast cancer. N Engl J Med 373:3 (2015), 209\u2013219.",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Palbociclib in hormone-receptor-positive advanced breast cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib7",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84937042338",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "373",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "209",
                                    "@last": "219"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "N.C.",
                                        "@_fa": "true",
                                        "ce:surname": "Turner",
                                        "ce:indexed-name": "Turner N.C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Ro",
                                        "ce:indexed-name": "Ro J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "F.",
                                        "@_fa": "true",
                                        "ce:surname": "Andre",
                                        "ce:indexed-name": "Andre F."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Turner NC, Ro J, Andre F, et al. Palbociclib in hormone-receptor-positive advanced breast cancer. N Engl J Med. 2015;373(3):209-219."
                    },
                    {
                        "ref-fulltext": "Cristofanilli, M., DeMichele, A., Giorgetti, C., et al. Predictors of prolonged benefit from palbociclib plus fulvestrant in women with endocrine-resistant hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer in PALOMA-3. Eur J Cancer 104 (2018), 21\u201331.",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Predictors of prolonged benefit from palbociclib plus fulvestrant in women with endocrine-resistant hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer in PALOMA-3"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib8",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85054384430",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "104"},
                                "pagerange": {
                                    "@first": "21",
                                    "@last": "31"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Cristofanilli",
                                        "ce:indexed-name": "Cristofanilli M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "DeMichele",
                                        "ce:indexed-name": "DeMichele A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Giorgetti",
                                        "ce:indexed-name": "Giorgetti C."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Eur J Cancer"
                        },
                        "ce:source-text": "Cristofanilli M, DeMichele A, Giorgetti C, et al. Predictors of prolonged benefit from palbociclib plus fulvestrant in women with endocrine-resistant hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer in PALOMA-3. Eur J Cancer. 2018;104:21-31."
                    },
                    {
                        "ref-fulltext": "Rugo, H.S., Finn, R.S., Dieras, V., et al. Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-up. Breast Cancer Res Treat 174:3 (2019), 719\u2013729.",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-up"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib9",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85059858271",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "174",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "719",
                                    "@last": "729"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "H.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Rugo",
                                        "ce:indexed-name": "Rugo H.S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "R.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Finn",
                                        "ce:indexed-name": "Finn R.S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "V.",
                                        "@_fa": "true",
                                        "ce:surname": "Dieras",
                                        "ce:indexed-name": "Dieras V."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Breast Cancer Res Treat"
                        },
                        "ce:source-text": "Rugo HS, Finn RS, Dieras V, et al. Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-up. Breast Cancer Res Treat. 2019;174(3):719-729."
                    },
                    {
                        "ref-fulltext": "Im, S.A., Mukai, H., Park, I.H., et al. Palbociclib plus letrozole as first-line therapy in postmenopausal Asian women with metastatic breast cancer: results from the phase III, randomized PALOMA-2 study. J Glob Oncol 5 (2019), 1\u201319.",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Palbociclib plus letrozole as first-line therapy in postmenopausal Asian women with metastatic breast cancer: results from the phase III, randomized PALOMA-2 study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib10",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85066946116",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "5"},
                                "pagerange": {
                                    "@first": "1",
                                    "@last": "19"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Im",
                                        "ce:indexed-name": "Im S.A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Mukai",
                                        "ce:indexed-name": "Mukai H."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "I.H.",
                                        "@_fa": "true",
                                        "ce:surname": "Park",
                                        "ce:indexed-name": "Park I.H."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Glob Oncol"
                        },
                        "ce:source-text": "Im SA, Mukai H, Park IH, et al. Palbociclib plus letrozole as first-line therapy in postmenopausal Asian women with metastatic breast cancer: results from the phase III, randomized PALOMA-2 study. J Glob Oncol. 2019;5:1-19."
                    },
                    {
                        "ref-fulltext": "Xu, B., Li, H., Zhang, Q., et al. Pharmacokinetics, safety, activity, and biomarker analysis of palbociclib plus letrozole as first-line treatment for ER+/HER2- advanced breast cancer in Chinese women. Cancer Chemother Pharmacol 88:1 (2021), 131\u2013141.",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Pharmacokinetics, safety, activity, and biomarker analysis of palbociclib plus letrozole as first-line treatment for ER+/HER2- advanced breast cancer in Chinese women"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib11",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85104140496",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "88",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "131",
                                    "@last": "141"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "B.",
                                        "@_fa": "true",
                                        "ce:surname": "Xu",
                                        "ce:indexed-name": "Xu B."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Li",
                                        "ce:indexed-name": "Li H."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "Q.",
                                        "@_fa": "true",
                                        "ce:surname": "Zhang",
                                        "ce:indexed-name": "Zhang Q."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer Chemother Pharmacol"
                        },
                        "ce:source-text": "Xu B, Li H, Zhang Q, et al. Pharmacokinetics, safety, activity, and biomarker analysis of palbociclib plus letrozole as first-line treatment for ER+/HER2- advanced breast cancer in Chinese women. Cancer Chemother Pharmacol. 2021;88(1):131-141."
                    },
                    {
                        "ref-fulltext": "Iwata, H., Im, S.A., Masuda, N., et al. PALOMA-3: phase III trial of fulvestrant with or without palbociclib in premenopausal and postmenopausal women with hormone receptor\u2013positive, human epidermal growth factor receptor 2\u2013negative metastatic breast cancer that progressed on prior endocrine therapy \u2013 safety and efficacy in Asian patients. J Glob Oncol 3:4 (2017), 289\u2013303.",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "PALOMA-3: phase III trial of fulvestrant with or without palbociclib in premenopausal and postmenopausal women with hormone receptor\u2013positive, human epidermal growth factor receptor 2\u2013negative metastatic breast cancer that progressed on prior endocrine therapy \u2013 safety and efficacy in Asian patients"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib12",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85020584632",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "3",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "289",
                                    "@last": "303"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Iwata",
                                        "ce:indexed-name": "Iwata H."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Im",
                                        "ce:indexed-name": "Im S.A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "N.",
                                        "@_fa": "true",
                                        "ce:surname": "Masuda",
                                        "ce:indexed-name": "Masuda N."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Glob Oncol"
                        },
                        "ce:source-text": "Iwata H, Im SA, Masuda N, et al. PALOMA-3: phase III trial of fulvestrant with or without palbociclib in premenopausal and postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer that progressed on prior endocrine therapy-safety and efficacy in Asian patients. J Glob Oncol. 2017;3(4):289-303."
                    },
                    {
                        "ref-fulltext": "Masuda, N., Inoue, K., Nakamura, R., et al. Palbociclib in combination with fulvestrant in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: PALOMA-3 subgroup analysis of Japanese patients. Int J Clin Oncol 24 (2019), 262\u2013273.",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Palbociclib in combination with fulvestrant in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: PALOMA-3 subgroup analysis of Japanese patients"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib13",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85055996638",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "24"},
                                "pagerange": {
                                    "@first": "262",
                                    "@last": "273"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "N.",
                                        "@_fa": "true",
                                        "ce:surname": "Masuda",
                                        "ce:indexed-name": "Masuda N."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Inoue",
                                        "ce:indexed-name": "Inoue K."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Nakamura",
                                        "ce:indexed-name": "Nakamura R."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Int J Clin Oncol"
                        },
                        "ce:source-text": "Masuda N, Inoue K, Nakamura R, et al. Palbociclib in combination with fulvestrant in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: PALOMA-3 subgroup analysis of Japanese patients. Int J Clin Oncol. 2019;24:262-273."
                    },
                    {
                        "ref-fulltext": "Mukai, H., Shimizu, C., Masuda, N., et al. Palbociclib in combination with letrozole in patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: PALOMA-2 subgroup analysis of Japanese patients. Int J Clin Oncol 24:3 (2019), 274\u2013287.",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Palbociclib in combination with letrozole in patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: PALOMA-2 subgroup analysis of Japanese patients"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib14",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85057742745",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "24",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "274",
                                    "@last": "287"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Mukai",
                                        "ce:indexed-name": "Mukai H."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Shimizu",
                                        "ce:indexed-name": "Shimizu C."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "N.",
                                        "@_fa": "true",
                                        "ce:surname": "Masuda",
                                        "ce:indexed-name": "Masuda N."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Int J Clin Oncol"
                        },
                        "ce:source-text": "Mukai H, Shimizu C, Masuda N, et al. Palbociclib in combination with letrozole in patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: PALOMA-2 subgroup analysis of Japanese patients. Int J Clin Oncol. 2019;24(3):274-287."
                    },
                    {
                        "ref-fulltext": "Kim, J.H., Im, S.A., Sim, S.H., et al. Palbociclib plus fulvestrant in Korean patients from PALOMA-3 with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer. J Breast Cancer 24:1 (2021), 97\u2013105.",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Palbociclib plus fulvestrant in Korean patients from PALOMA-3 with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib15",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85102299885",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "24",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "97",
                                    "@last": "105"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.H.",
                                        "@_fa": "true",
                                        "ce:surname": "Kim",
                                        "ce:indexed-name": "Kim J.H."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Im",
                                        "ce:indexed-name": "Im S.A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.H.",
                                        "@_fa": "true",
                                        "ce:surname": "Sim",
                                        "ce:indexed-name": "Sim S.H."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Breast Cancer"
                        },
                        "ce:source-text": "Kim JH, Im SA, Sim SH, et al. Palbociclib plus fulvestrant in Korean patients from PALOMA-3 with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer. J Breast Cancer. 2021;24(1):97-105."
                    },
                    {
                        "ref-fulltext": "Zhang, Q.Y., Sun, T., Yin, Y.M., et al. MONARCH plus: abemaciclib plus endocrine therapy in women with HR+/HER2- advanced breast cancer: the multinational randomized phase III study. Ther Adv Med Oncol, 12, 2020, 1758835920963925.",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "MONARCH plus: abemaciclib plus endocrine therapy in women with HR+/HER2- advanced breast cancer: the multinational randomized phase III study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib16",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "1758835920963925",
                                    "@idtype": "ARTNUM"
                                },
                                {
                                    "$": "85093965366",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {"@volume": "12"}},
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "Q.Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Zhang",
                                        "ce:indexed-name": "Zhang Q.Y."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Sun",
                                        "ce:indexed-name": "Sun T."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "Y.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Yin",
                                        "ce:indexed-name": "Yin Y.M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ther Adv Med Oncol"
                        },
                        "ce:source-text": "Zhang QY, Sun T, Yin YM, et al. MONARCH plus: abemaciclib plus endocrine therapy in women with HR+/HER2- advanced breast cancer: the multinational randomized phase III study. Ther Adv Med Oncol. 2020;12:1758835920963925."
                    },
                    {
                        "ref-fulltext": "Xu, B., Zhang, Q., Zhang, P., et al. Dalpiciclib or placebo plus fulvestrant in hormone receptor-positive and HER2-negative advanced breast cancer: a randomized, phase 3 trial. Nat Med 27:11 (2021), 1904\u20131909.",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Dalpiciclib or placebo plus fulvestrant in hormone receptor-positive and HER2-negative advanced breast cancer: a randomized, phase 3 trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib17",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85118888923",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "27",
                                    "@issue": "11"
                                },
                                "pagerange": {
                                    "@first": "1904",
                                    "@last": "1909"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "B.",
                                        "@_fa": "true",
                                        "ce:surname": "Xu",
                                        "ce:indexed-name": "Xu B."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "Q.",
                                        "@_fa": "true",
                                        "ce:surname": "Zhang",
                                        "ce:indexed-name": "Zhang Q."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Zhang",
                                        "ce:indexed-name": "Zhang P."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Nat Med"
                        },
                        "ce:source-text": "Xu B, Zhang Q, Zhang P, et al. Dalpiciclib or placebo plus fulvestrant in hormone receptor-positive and HER2-negative advanced breast cancer: a randomized, phase 3 trial. Nat Med. 2021;27(11):1904-1909."
                    },
                    {
                        "ref-fulltext": "Dieras, V., Harbeck, N., Joy, A.A., et al. Palbociclib with letrozole in postmenopausal women with ER+/HER2- advanced breast cancer: hematologic safety analysis of the randomized PALOMA-2 trial. Oncologist 24:12 (2019), 1514\u20131525.",
                        "@id": "18",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Palbociclib with letrozole in postmenopausal women with ER+/HER2- advanced breast cancer: hematologic safety analysis of the randomized PALOMA-2 trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib18",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85067918975",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "24",
                                    "@issue": "12"
                                },
                                "pagerange": {
                                    "@first": "1514",
                                    "@last": "1525"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "V.",
                                        "@_fa": "true",
                                        "ce:surname": "Dieras",
                                        "ce:indexed-name": "Dieras V."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "N.",
                                        "@_fa": "true",
                                        "ce:surname": "Harbeck",
                                        "ce:indexed-name": "Harbeck N."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Joy",
                                        "ce:indexed-name": "Joy A.A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Oncologist"
                        },
                        "ce:source-text": "Dieras V, Harbeck N, Joy AA, et al. Palbociclib with letrozole in postmenopausal women with ER+/HER2- advanced breast cancer: hematologic safety analysis of the randomized PALOMA-2 trial. Oncol. 2019;24(12):1514-1525."
                    },
                    {
                        "ref-fulltext": "Dieras, V., Rugo, H.S., Schnell, P., et al. Long-term pooled safety analysis of palbociclib in combination with endocrine therapy for HR+/HER2- advanced breast cancer. J Natl Cancer Inst 111:4 (2019), 419\u2013430.",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Long-term pooled safety analysis of palbociclib in combination with endocrine therapy for HR+/HER2- advanced breast cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib19",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85059123658",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "111",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "419",
                                    "@last": "430"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "V.",
                                        "@_fa": "true",
                                        "ce:surname": "Dieras",
                                        "ce:indexed-name": "Dieras V."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "H.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Rugo",
                                        "ce:indexed-name": "Rugo H.S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Schnell",
                                        "ce:indexed-name": "Schnell P."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Natl Cancer Inst"
                        },
                        "ce:source-text": "Dieras V, Rugo HS, Schnell P, et al. Long-term pooled safety analysis of palbociclib in combination with endocrine therapy for HR+/HER2- advanced breast cancer. J Natl Cancer Inst. 2019;111(4):419-430."
                    },
                    {
                        "ref-fulltext": "Finn, R.S., Rugo, H.S., Gelmon, K.A., et al. Long-term pooled safety analysis of palbociclib in combination with endocrine therapy for hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: updated analysis with up to 5 years of follow-up. Oncologist 26:5 (2021), e749\u2013e755.",
                        "@id": "20",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Long-term pooled safety analysis of palbociclib in combination with endocrine therapy for hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: updated analysis with up to 5 years of follow-up"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib20",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85102454338",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "26",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "e749",
                                    "@last": "e755"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "R.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Finn",
                                        "ce:indexed-name": "Finn R.S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "H.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Rugo",
                                        "ce:indexed-name": "Rugo H.S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Gelmon",
                                        "ce:indexed-name": "Gelmon K.A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Oncologist"
                        },
                        "ce:source-text": "Finn RS, Rugo HS, Gelmon KA, et al. Long-term pooled safety analysis of palbociclib in combination with endocrine therapy for hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: updated analysis with up to 5 years of follow-up. Oncol. 2021;26(5):e749-e755."
                    },
                    {
                        "ref-fulltext": "Verma, S., Bartlett, C.H., Schnell, P., et al. Palbociclib in combination with fulvestrant in women with hormone receptor-positive/HER2-negative advanced metastatic breast cancer: detailed safety analysis from a multicenter, randomized, placebo-controlled, phase III study (PALOMA-3). Oncologist 21:10 (2016), 1165\u20131175.",
                        "@id": "21",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Palbociclib in combination with fulvestrant in women with hormone receptor-positive/HER2-negative advanced metastatic breast cancer: detailed safety analysis from a multicenter, randomized, placebo-controlled, phase III study (PALOMA-3)"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib21",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84991660586",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "21",
                                    "@issue": "10"
                                },
                                "pagerange": {
                                    "@first": "1165",
                                    "@last": "1175"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Verma",
                                        "ce:indexed-name": "Verma S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C.H.",
                                        "@_fa": "true",
                                        "ce:surname": "Bartlett",
                                        "ce:indexed-name": "Bartlett C.H."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Schnell",
                                        "ce:indexed-name": "Schnell P."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Oncologist"
                        },
                        "ce:source-text": "Verma S, Bartlett CH, Schnell P, et al. Palbociclib in combination with fulvestrant in women with hormone receptor-positive/HER2-negative advanced metastatic breast cancer: detailed safety analysis from a multicenter, randomized, placebo-controlled, phase III study (PALOMA-3). Oncol. 2016;21(10):1165-1175."
                    },
                    {
                        "ref-fulltext": "Ettl, J., Im, S.A., Ro, J., et al. Hematologic adverse events following palbociclib dose reduction in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: pooled analysis from randomized phase 2 and 3 studies. Breast Cancer Res, 22(1), 2020, 27.",
                        "@id": "22",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Hematologic adverse events following palbociclib dose reduction in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: pooled analysis from randomized phase 2 and 3 studies"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib22",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85081754604",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "22",
                                    "@issue": "1"
                                },
                                "pagerange": {"@first": "27"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Ettl",
                                        "ce:indexed-name": "Ettl J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Im",
                                        "ce:indexed-name": "Im S.A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Ro",
                                        "ce:indexed-name": "Ro J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Breast Cancer Res"
                        },
                        "ce:source-text": "Ettl J, Im SA, Ro J, et al. Hematologic adverse events following palbociclib dose reduction in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: pooled analysis from randomized phase 2 and 3 studies. Breast Cancer Res. 2020;22(1):27."
                    },
                    {
                        "ref-fulltext": "Zheng, J., Yu, Y., Durairaj, C., et al. Impact of dose reduction on efficacy: implications of exposure-response analysis of palbociclib. Target Oncol 16:1 (2021), 69\u201376.",
                        "@id": "23",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Impact of dose reduction on efficacy: implications of exposure-response analysis of palbociclib"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib23",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85096340087",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "16",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "69",
                                    "@last": "76"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Zheng",
                                        "ce:indexed-name": "Zheng J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Yu",
                                        "ce:indexed-name": "Yu Y."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Durairaj",
                                        "ce:indexed-name": "Durairaj C."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Target Oncol"
                        },
                        "ce:source-text": "Zheng J, Yu Y, Durairaj C, et al. Impact of dose reduction on efficacy: implications of exposure-response analysis of palbociclib. Target Oncol. 2021;16(1):69-76."
                    },
                    {
                        "ref-fulltext": "Sacaan, A.I., Thibault, S., Hong, M., et al. CDK4/6 inhibition on glucose and pancreatic beta cell homeostasis in young and aged rats. Mol Cancer Res 15:11 (2017), 1531\u20131541.",
                        "@id": "24",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "CDK4/6 inhibition on glucose and pancreatic beta cell homeostasis in young and aged rats"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib24",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85032835765",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "15",
                                    "@issue": "11"
                                },
                                "pagerange": {
                                    "@first": "1531",
                                    "@last": "1541"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.I.",
                                        "@_fa": "true",
                                        "ce:surname": "Sacaan",
                                        "ce:indexed-name": "Sacaan A.I."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Thibault",
                                        "ce:indexed-name": "Thibault S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Hong",
                                        "ce:indexed-name": "Hong M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Mol Cancer Res"
                        },
                        "ce:source-text": "Sacaan AI, Thibault S, Hong M, et al. CDK4/6 inhibition on glucose and pancreatic beta cell homeostasis in young and aged rats. Mol Cancer Res. 2017;15(11):1531-1541."
                    }
                ]
            }}
        }
    },
    "affiliation": [
        {
            "affiliation-city": "Changchun",
            "@id": "60122381",
            "affilname": "The First Bethune Hospital of Jilin University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60122381",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Shanghai",
            "@id": "60108904",
            "affilname": "Fudan University Shanghai Cancer Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60108904",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Guangzhou",
            "@id": "60082502",
            "affilname": "Sun Yat-Sen University Cancer Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60082502",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Changchun",
            "@id": "60082194",
            "affilname": "Jilin Provincial Cancer Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60082194",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Beijing",
            "@id": "60073456",
            "affilname": "Cancer Institute &amp; Hospital, Chinese Academy of Medical Sciences &amp; Peking Union Medical College",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60073456",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Taipei",
            "@id": "60025370",
            "affilname": "National Taiwan University College of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60025370",
            "affiliation-country": "Taiwan"
        },
        {
            "affiliation-city": "Shanghai",
            "@id": "60024452",
            "affilname": "Ruijin Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60024452",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Harbin",
            "@id": "60021615",
            "affilname": "Harbin Medical University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60021615",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Guangzhou",
            "@id": "60021182",
            "affilname": "Sun Yat-Sen University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60021182",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Tianjin",
            "@id": "60017260",
            "affilname": "Tianjin Medical University Cancer Institute &amp; Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60017260",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Shijiazhuang",
            "@id": "60009884",
            "affilname": "Hebei Medical University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009884",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Shenyang",
            "@id": "60008872",
            "affilname": "China Medical University Shenyang",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60008872",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "New York",
            "@id": "60006989",
            "affilname": "Pfizer Inc.",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006989",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Hong Kong",
            "@id": "60006541",
            "affilname": "The University of Hong Kong",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006541",
            "affiliation-country": "Hong Kong"
        },
        {
            "affiliation-city": "Singapore City",
            "@id": "60002481",
            "affilname": "Tan Tock Seng Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002481",
            "affiliation-country": "Singapore"
        },
        {
            "affiliation-city": "Zhengzhou",
            "@id": "128127093",
            "affilname": "Henan Cancer Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/128127093",
            "affiliation-country": "China"
        }
    ],
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85138510141",
        "dc:description": "Background: The cyclin-dependent kinase 4/6 inhibitor palbociclib has demonstrated efficacy and a manageable safety profile in combination with endocrine therapy in women with oestrogen receptor\u2013positive (ER+)/human epidermal growth factor receptor 2\u2013negative (HER2\u2013) advanced breast cancer (ABC) in international phase 3 trials. The phase 3 PALOMA-4 trial evaluated the efficacy and safety of palbociclib plus letrozole versus placebo plus letrozole in Asian women with ER+/HER2\u2013 ABC. Methods: Postmenopausal women (n = 340) with no prior systemic treatment for advanced disease were randomised 1:1 to palbociclib (125 mg/d orally; 3 weeks on, 1 week off) plus letrozole (2.5 mg/d orally; continuously) or placebo plus letrozole. The primary end-point was investigator-assessed progression-free survival (PFS). Secondary end-points included tumour response and safety. Results: Median (95% CI) PFS was 21.5 (16.6\u201324.9) months with palbociclib plus letrozole and 13.9 (13.7\u201316.6) months with placebo plus letrozole (hazard ratio, 0.68 [95% CI, 0.53\u20130.87]; P = 0.0012). Consistent with the established safety profile, the most common adverse events (AEs) with palbociclib plus letrozole were neutropenia, leukopenia, thrombocytopaenia, and anaemia. Grade 3/4 neutropenia was reported in 84.5% of patients in the palbociclib arm versus 1.2% in the placebo arm. One serious AE of febrile neutropenia in the palbociclib group was reported. Conclusions: Findings from PALOMA-4 support the efficacy and safety of first-line palbociclib plus letrozole in postmenopausal Asian women with ER+/HER2\u2013 ABC. No new safety concerns of palbociclib plus letrozole were identified. Trial registration: Clinicaltrials. gov, NCT02297438.",
        "pubmed-id": "36155117",
        "prism:coverDate": "2022-11-01",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85138510141",
        "dc:creator": {"author": [{
            "ce:given-name": "Binghe",
            "preferred-name": {
                "ce:given-name": "Binghe",
                "ce:initials": "B.",
                "ce:surname": "Xu",
                "ce:indexed-name": "Xu B."
            },
            "@seq": "1",
            "ce:initials": "B.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60073456",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60073456"
            },
            "ce:surname": "Xu",
            "@auid": "7404589280",
            "author-url": "https://api.elsevier.com/content/author/author_id/7404589280",
            "ce:indexed-name": "Xu B."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85138510141"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85138510141&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85138510141&origin=inward"
            }
        ],
        "source-id": "29761",
        "pii": "S0959804922004890",
        "citedby-count": "9",
        "prism:volume": "175",
        "subtype": "ar",
        "dc:title": "Palbociclib plus letrozole versus placebo plus letrozole in Asian postmenopausal women with oestrogen receptor\u2013positive/human epidermal growth factor receptor 2\u2013negative advanced breast cancer: Primary results from PALOMA-4",
        "openaccess": "1",
        "prism:issn": "18790852 09598049",
        "publishercopyright": "© 2022 Elsevier Ltd",
        "subtypeDescription": "Article",
        "prism:publicationName": "European Journal of Cancer",
        "prism:pageRange": "236-245",
        "prism:endingPage": "245",
        "openaccessFlag": "true",
        "prism:doi": "10.1016/j.ejca.2022.08.012",
        "prism:startingPage": "236",
        "dc:identifier": "SCOPUS_ID:85138510141",
        "dc:publisher": "Elsevier Ltd"
    },
    "idxterms": {"mainterm": [
        {
            "$": "Antineoplastic Combined Chemotherapy Protocols",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Breast Neoplasms",
            "@weight": "a",
            "@candidate": "n"
        },
        {
            "$": "Cyclin-Dependent Kinase 4",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Female",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Humans",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Letrozole",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Neutropenia",
            "@weight": "a",
            "@candidate": "n"
        },
        {
            "$": "Piperazines",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Postmenopause",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Pyridines",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Receptor, ErbB-2",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Receptors, Estrogen",
            "@weight": "b",
            "@candidate": "n"
        }
    ]},
    "language": {"@xml:lang": "eng"},
    "authkeywords": {"author-keyword": [
        {
            "@_fa": "true",
            "$": "Advanced breast cancer"
        },
        {
            "@_fa": "true",
            "$": "Asian"
        },
        {
            "@_fa": "true",
            "$": "Letrozole"
        },
        {
            "@_fa": "true",
            "$": "Oestrogen receptor\u2013positive"
        },
        {
            "@_fa": "true",
            "$": "Palbociclib"
        }
    ]},
    "subject-areas": {"subject-area": [
        {
            "@_fa": "true",
            "$": "Oncology",
            "@code": "2730",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Cancer Research",
            "@code": "1306",
            "@abbrev": "BIOC"
        }
    ]},
    "authors": {"author": [
        {
            "ce:given-name": "Binghe",
            "preferred-name": {
                "ce:given-name": "Binghe",
                "ce:initials": "B.",
                "ce:surname": "Xu",
                "ce:indexed-name": "Xu B."
            },
            "@seq": "1",
            "ce:initials": "B.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60073456",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60073456"
            },
            "ce:surname": "Xu",
            "@auid": "7404589280",
            "author-url": "https://api.elsevier.com/content/author/author_id/7404589280",
            "ce:indexed-name": "Xu B."
        },
        {
            "ce:given-name": "Xichun",
            "preferred-name": {
                "ce:given-name": "Xichun",
                "ce:initials": "X.",
                "ce:surname": "Hu",
                "ce:indexed-name": "Hu X."
            },
            "@seq": "2",
            "ce:initials": "X.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60108904",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60108904"
            },
            "ce:surname": "Hu",
            "@auid": "57216569158",
            "author-url": "https://api.elsevier.com/content/author/author_id/57216569158",
            "ce:indexed-name": "Hu X."
        },
        {
            "ce:given-name": "Wei",
            "preferred-name": {
                "ce:given-name": "Wei",
                "ce:initials": "W.",
                "ce:surname": "Li",
                "ce:indexed-name": "Li W."
            },
            "@seq": "3",
            "ce:initials": "W.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60122381",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60122381"
            },
            "ce:surname": "Li",
            "@auid": "57196305473",
            "author-url": "https://api.elsevier.com/content/author/author_id/57196305473",
            "ce:indexed-name": "Li W."
        },
        {
            "ce:given-name": "Tao",
            "preferred-name": {
                "ce:given-name": "Tao",
                "ce:initials": "T.",
                "ce:surname": "Sun",
                "ce:indexed-name": "Sun T."
            },
            "@seq": "4",
            "ce:initials": "T.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60008872",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60008872"
            },
            "ce:surname": "Sun",
            "@auid": "35235673700",
            "author-url": "https://api.elsevier.com/content/author/author_id/35235673700",
            "ce:indexed-name": "Sun T."
        },
        {
            "ce:given-name": "Kunwei",
            "preferred-name": {
                "ce:given-name": "Kunwei",
                "ce:initials": "K.",
                "ce:surname": "Shen",
                "ce:indexed-name": "Shen K."
            },
            "@seq": "5",
            "ce:initials": "K.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60024452",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60024452"
            },
            "ce:surname": "Shen",
            "@auid": "7201458295",
            "author-url": "https://api.elsevier.com/content/author/author_id/7201458295",
            "ce:indexed-name": "Shen K."
        },
        {
            "ce:given-name": "Shusen",
            "preferred-name": {
                "ce:given-name": "Shusen",
                "ce:initials": "S.",
                "ce:surname": "Wang",
                "ce:indexed-name": "Wang S."
            },
            "@seq": "6",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60082502",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60082502"
            },
            "ce:surname": "Wang",
            "@auid": "36807318600",
            "author-url": "https://api.elsevier.com/content/author/author_id/36807318600",
            "ce:indexed-name": "Wang S."
        },
        {
            "ce:given-name": "Ying",
            "preferred-name": {
                "ce:given-name": "Ying",
                "ce:initials": "Y.",
                "ce:surname": "Cheng",
                "ce:indexed-name": "Cheng Y."
            },
            "@seq": "7",
            "ce:initials": "Y.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60082194",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60082194"
            },
            "ce:surname": "Cheng",
            "@auid": "9437171300",
            "author-url": "https://api.elsevier.com/content/author/author_id/9437171300",
            "ce:indexed-name": "Cheng Y."
        },
        {
            "ce:given-name": "Qingyuan",
            "preferred-name": {
                "ce:given-name": "Qingyuan",
                "ce:initials": "Q.",
                "ce:surname": "Zhang",
                "ce:indexed-name": "Zhang Q."
            },
            "@seq": "8",
            "ce:initials": "Q.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60021615",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60021615"
            },
            "ce:surname": "Zhang",
            "@auid": "36492586800",
            "author-url": "https://api.elsevier.com/content/author/author_id/36492586800",
            "ce:indexed-name": "Zhang Q."
        },
        {
            "ce:given-name": "Shude",
            "preferred-name": {
                "ce:given-name": "Shude",
                "ce:initials": "S.",
                "ce:surname": "Cui",
                "ce:indexed-name": "Cui S."
            },
            "@seq": "9",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "128127093",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/128127093"
            },
            "ce:surname": "Cui",
            "@auid": "7202413749",
            "author-url": "https://api.elsevier.com/content/author/author_id/7202413749",
            "ce:indexed-name": "Cui S."
        },
        {
            "ce:given-name": "Zhongsheng",
            "preferred-name": {
                "ce:given-name": "Zhongsheng",
                "ce:initials": "Z.",
                "ce:surname": "Tong",
                "ce:indexed-name": "Tong Z."
            },
            "@seq": "10",
            "ce:initials": "Z.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60017260",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60017260"
            },
            "ce:surname": "Tong",
            "@auid": "14014497700",
            "author-url": "https://api.elsevier.com/content/author/author_id/14014497700",
            "ce:indexed-name": "Tong Z."
        },
        {
            "ce:given-name": "Cuizhi",
            "preferred-name": {
                "ce:given-name": "Cuizhi",
                "ce:initials": "C.",
                "ce:surname": "Geng",
                "ce:indexed-name": "Geng C."
            },
            "@seq": "11",
            "ce:initials": "C.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60009884",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009884"
            },
            "ce:surname": "Geng",
            "@auid": "26425095100",
            "author-url": "https://api.elsevier.com/content/author/author_id/26425095100",
            "ce:indexed-name": "Geng C."
        },
        {
            "ce:given-name": "Erwei",
            "preferred-name": {
                "ce:given-name": "Erwei",
                "ce:initials": "E.",
                "ce:surname": "Song",
                "ce:indexed-name": "Song E."
            },
            "@seq": "12",
            "ce:initials": "E.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60021182",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60021182"
            },
            "ce:surname": "Song",
            "@auid": "7101904256",
            "author-url": "https://api.elsevier.com/content/author/author_id/7101904256",
            "ce:indexed-name": "Song E."
        },
        {
            "ce:given-name": "Chiun-Sheng",
            "preferred-name": {
                "ce:given-name": "Chiun Sheng",
                "ce:initials": "C.S.",
                "ce:surname": "Huang",
                "ce:indexed-name": "Huang C.S."
            },
            "@seq": "13",
            "ce:initials": "C.-S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60025370",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60025370"
            },
            "ce:surname": "Huang",
            "@auid": "57217997695",
            "author-url": "https://api.elsevier.com/content/author/author_id/57217997695",
            "ce:indexed-name": "Huang C.-S."
        },
        {
            "ce:given-name": "Virote",
            "preferred-name": {
                "ce:given-name": "Virote",
                "ce:initials": "V.",
                "ce:surname": "Sriuranpong",
                "ce:indexed-name": "Sriuranpong V."
            },
            "@seq": "14",
            "ce:initials": "V.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60022183",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183"
            },
            "ce:surname": "Sriuranpong",
            "@auid": "6603599644",
            "author-url": "https://api.elsevier.com/content/author/author_id/6603599644",
            "ce:indexed-name": "Sriuranpong V."
        },
        {
            "ce:given-name": "Roger K.C.",
            "preferred-name": {
                "ce:given-name": "Roger K.C.",
                "ce:initials": "R.K.C.",
                "ce:surname": "Ngan",
                "ce:indexed-name": "Ngan R.K.C."
            },
            "@seq": "15",
            "ce:initials": "R.K.C.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60006541",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006541"
            },
            "ce:surname": "Ngan",
            "@auid": "57222641833",
            "author-url": "https://api.elsevier.com/content/author/author_id/57222641833",
            "ce:indexed-name": "Ngan R.K.C."
        },
        {
            "ce:given-name": "Yee H.",
            "preferred-name": {
                "ce:given-name": "Yee H.",
                "ce:initials": "Y.H.",
                "ce:surname": "Chia",
                "ce:indexed-name": "Chia Y.H."
            },
            "@seq": "16",
            "ce:initials": "Y.H.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60002481",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002481"
            },
            "ce:surname": "Chia",
            "@auid": "35290374300",
            "author-url": "https://api.elsevier.com/content/author/author_id/35290374300",
            "ce:indexed-name": "Chia Y.H."
        },
        {
            "ce:given-name": "Xinwei",
            "preferred-name": {
                "ce:given-name": "Xinwei",
                "ce:initials": "X.",
                "ce:surname": "Wang",
                "ce:indexed-name": "Wang X."
            },
            "@seq": "17",
            "ce:initials": "X.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60006989",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006989"
            },
            "ce:surname": "Wang",
            "@auid": "57900513500",
            "author-url": "https://api.elsevier.com/content/author/author_id/57900513500",
            "ce:indexed-name": "Wang X."
        },
        {
            "ce:given-name": "Huadong",
            "preferred-name": {
                "ce:given-name": "Huadong",
                "ce:initials": "H.",
                "ce:surname": "Zhao",
                "ce:indexed-name": "Zhao H."
            },
            "@seq": "18",
            "ce:initials": "H.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60006989",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006989"
            },
            "ce:surname": "Zhao",
            "@auid": "57222871740",
            "author-url": "https://api.elsevier.com/content/author/author_id/57222871740",
            "ce:indexed-name": "Zhao H."
        }
    ]}
}}